Keywords: CNS; central nervous system; GFAP; glial fibrilary acidic protein; OGD; oxygen-glucose deprivation; Intermediate filaments (nanofilaments); Astrocytes; Clomipramine; Epoxomicin; Neuroprotection; Oxygen and glucose deprivation; Oxidative stress;